62 results on '"Lanctôt, Krista L."'
Search Results
2. Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
3. Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis
4. Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes
5. Identifying factors influencing cognitive outcomes after anodal transcranial direct current stimulation in older adults with and without cognitive impairment: A systematic review
6. P93. Inflammatory Markers in Type 2 Diabetes and Cognitive Impairment: A Systematic Review and Meta-Analysis
7. Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis
8. Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials
9. Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects
10. Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers
11. The potential roles of excitatory-inhibitory imbalances and the repressor element-1 silencing transcription factor in aging and aging-associated diseases
12. Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer’s disease and mild cognitive impairment: A meta-analysis and systematic review
13. Mirtazapine for agitation in dementia: moving forward
14. Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes
15. Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
16. The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect
17. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments
18. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
19. Serum osteocalcin is associated with subjective stress in people with depression and type 2 diabetes
20. Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid
21. Relationships Between Serum Osteocalcin, Brain Derived Neurotrophic Factor and Subjective Stress in People With and Without Depression and Type 2 Diabetes Mellitus
22. Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review
23. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
24. Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
25. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment
26. Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients
27. The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis
28. Suicide deaths by intentional self-poisoning in people with cardiovascular disease
29. Understanding the Link between Neuropsychiatric Symptoms and Cognitive Decline: Insights From Neuroimaging
30. Global grey matter volume in adult bipolar patients with and without lithium treatment: A meta-analysis
31. Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis
32. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease
33. Ceramides and depression: A systematic review
34. Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients
35. Suicide in males and females with cardiovascular disease and comorbid depression
36. Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients
37. A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease
38. White Matter Microstructural Integrity Is Associated with Executive Function and Processing Speed in Older Adults with Coronary Artery Disease
39. Cholinesterase Inhibitor Discontinuation in Institutionalized Persons with Moderate to Severe AD: Results of a Double-Blind, Placebo Controlled Trial
40. Reply to: Serum Zinc and the Risk of Depression in Men: Observations from a 20-Year Follow-up Study
41. Depressive Symptoms Predict Non-Adherence to Exercise-Based Rehabilitation in Participants with Type 2 Diabetes Mellitus
42. Predictors of readmission to a psychiatry inpatient unit
43. The Platelet Activating Factor PC(O-18:3/2:0) is Associated with Apathy Independently of Depressive Symptoms in Depressed Patients with Coronary Artery Disease
44. Zinc in Depression: A Meta-Analysis
45. Platelet activating factors in depression and coronary artery disease: A potential biomarker related to inflammatory mechanisms and neurodegeneration
46. Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET)
47. Interleukin-17 in post-stroke neurodegeneration
48. Computerized cognitive testing for patients with multiple sclerosis
49. Serotonergic Function and Treatment of Behavioral and Psychological Symptoms of Frontotemporal Dementia
50. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.